《BioRxiv,4月24日,ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-04-26
  • ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study

    Matteo Calcagnile, Patricia Forgez, Antonio Iannelli, Cecilia Bucci, Marco Alifano, Pietro Alifano

    doi: https://doi.org/10.1101/2020.04.23.057042

    Abstract

    The current SARS covid-19 epidemic spread appears to be influenced by ethnical, geographical and sex-related factors that may involve genetic susceptibility to diseases. Similar to SARS-CoV, SARS-CoV-2 exploits angiotensin-converting enzyme 2 (ACE2) as a receptor to invade cells, notably type II alveolar epithelial cells. Importantly, ACE2 gene is highly polymorphic. Here we have used in silico tools to analyze the possible impact of ACE2 single-nucleotide polymorphisms (SNPs) on the interaction with SARS-CoV-2 spike glycoprotein. We found that S19P (common in African people) and K26R (common in European people) were, among the most diffused SNPs worldwide, the only two SNPs that were able to potentially affect the interaction of ACE2 with SARS-CoV-2 spike. FireDock simulations demonstrated that while S19P may decrease, K26R might increase the ACE2 affinity for SARS-CoV-2 Spike. This finding suggests that the S19P may genetically protect, and K26R may predispose to more severe SARS-CoV-2 disease.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.biorxiv.org/content/10.1101/2020.04.23.057042v1
相关报告
  • 《BioRxiv,5月9日,ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-05-11
    • ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection View ORCID ProfileLingli Zhou, Zhenhua Xu, View ORCID ProfileGianni M Castiglione, Uri S Soiberman, Charles G Eberhart, Elia J Duh doi: https://doi.org/10.1101/2020.05.09.086165 Abstract Purpose: Conjunctival signs and symptoms are observed in a subset of patients with COVID-19, and SARS-CoV-2 has been detected in tears, raising concerns regarding the eye both as a portal of entry and carrier of the virus. The purpose of this study was to determine whether ocular surface cells possess the key factors required for cellular susceptibility to SARS-CoV-2 entry/infection. Methods: We analyzed human post-mortem eyes as well as surgical specimens for the expression of ACE2 (the receptor for SARS-CoV-2) and TMPRSS2, a cell surface-associated protease that facilitates viral entry following binding of the viral spike protein to ACE2. Results: Across all eye specimens, immunohistochemical analysis revealed expression of ACE2 in the conjunctiva, limbus, and cornea, with especially prominent staining in the superficial conjunctival and corneal epithelial surface. Surgical conjunctival specimens also showed expression of ACE2 in the conjunctival epithelium, especially prominent in the superficial epithelium, as well as the substantia propria. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《4月24日_意大利和法国科学家团队基于in silico分析研究ACE2基因多态性和SARS-CoV-2感染的个体易感性》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-04-26
    • 信息名称:意大利和法国科学家团队基于in silico分析研究ACE2基因多态性和SARS-CoV-2感染的个体易感性 1.时间:2020年4月24日 2.机构或团队:意大利萨伦托大学、法国国家与健康医学研究院(INSERM)、法国尼斯大学、巴黎大学 3.事件概要: 4月24日,bioRxiv发表了题为“ACE2 polymorphisms and individual susceptibility to SARS-CoV-2 infection: insights from an in silico study”的文章。 目前COVID-19的流行似乎受到种族、地理和性别相关因素的影响,这些因素可能涉及对疾病的遗传易感性。与SARS-CoV相似,SARS-CoV-2利用血管紧张素转换酶2(ACE2)作为受体入侵细胞,尤其是肺泡上皮细胞II型。重要的是,ACE2基因具有高度多态性。在这个文章里,作者利用in silico方法分析了ACE2单核苷酸多态性(SNPs)对SARS-CoV-2棘突糖蛋白相互作用的可能影响。结果发现,世界上分布最广的两种SNP—S19P(在非洲人群中常见)和K26R(在欧洲人群中常见)是能够潜在影响ACE2与SARS-CoV-2相互作用的仅有的两种SNP。FireDock模拟表明,S19P可能降低、K26R可能增加ACE2对SARS-CoV-2的亲和力。这一发现表明,S19P可能具有遗传保护作用,K26R可能易患更严重的SARS-CoV-2疾病。 *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用。 4.附件: 原文链接 https://www.biorxiv.org/content/10.1101/2020.04.23.057042v1